- Home
- ROIV vs AWK Comparison
ROIV vs AWK Comparison
Compare ROIV & AWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | AWK |
|---|---|---|
| Founded | 2014 | 1886 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 25.9B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ROIV | AWK |
|---|---|---|
| Price | $34.80 | $136.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | $28.94 | ★ $138.27 |
| AVG Volume (30 Days) | ★ 5.8M | 2.1M |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.51% |
| EPS Growth | N/A | ★ 5.57 |
| EPS | N/A | ★ 1.00 |
| Revenue | $8,260,000.00 | ★ $3,011,328,000.00 |
| Revenue This Year | N/A | $6.09 |
| Revenue Next Year | $744.61 | $6.90 |
| P/E Ratio | ★ N/A | $136.53 |
| Revenue Growth | N/A | ★ 3.77 |
| 52 Week Low | $10.71 | $120.57 |
| 52 Week High | $35.90 | $147.87 |
Technical Indicators
Market Signals| Indicator | ROIV | AWK |
|---|---|---|
| Relative Strength Index (RSI) | 71.26 | 70.99 |
| Support Level | $26.65 | $135.02 |
| Resistance Level | N/A | $140.11 |
| Average True Range (ATR) | 1.17 | 2.99 |
| MACD | 0.39 | 1.05 |
| Stochastic Oscillator | 82.59 | 99.49 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AWK American Water Works Company Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving nearly 4 million customers in 14 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns. The proposed Essential Utilities acquisition would add regulated water and wastewater utilities in Ohio, North Carolina, and Texas while increasing its presence in Illinois, Indiana, Pennsylvania, New Jersey, and Virginia.